Cargando…

Editorial: Neurological Soft Signs in Neuropsychiatric Conditions

Detalles Bibliográficos
Autores principales:	Toro, Pablo, Schröder, Johannes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339934/ https://www.ncbi.nlm.nih.gov/pubmed/30692941 http://dx.doi.org/10.3389/fpsyt.2018.00736

Ejemplares similares

Neurological Soft Signs in Aging, Mild Cognitive Impairment, and Alzheimer’s Disease – The Impact of Cognitive Decline and Cognitive Reserve
por: Urbanowitsch, Nadja, et al.
Publicado: (2015)

Neurological Soft Signs in Schizophrenia: An Update on the State- versus Trait-Perspective
por: Bachmann, Silke, et al.
Publicado: (2018)

Neurological Soft Signs in the Clinical Course of Schizophrenia: Results of a Meta-Analysis
por: Bachmann, Silke, et al.
Publicado: (2014)

Neurological Soft Signs and Psychopathology in Chronic Schizophrenia: A Cross-Sectional Study in Three Age Groups
por: Herold, Christina J., et al.
Publicado: (2018)

Neurological soft signs and brain morphology in people living with HIV
por: Herold, Christina J., et al.
Publicado: (2022)

Neurological Soft Signs and Post-Traumatic Stress Disorder: A Biomarker of Severity?
por: Belrose, Célia, et al.
Publicado: (2020)

Editorial: The heterogeneity of neuropsychiatric disorders
por: Wu, Zhao-Min, et al.
Publicado: (2023)

Default Mode Network Aberrant Connectivity Associated with Neurological Soft Signs in Schizophrenia Patients and Unaffected Relatives
por: Galindo, Liliana, et al.
Publicado: (2018)

Neurological Soft Signs, Spontaneous and Treatment Emergent Extrapyramidal Syndromes in Black Africans With First Episode Schizophrenia
por: Ojagbemi, Akin, et al.
Publicado: (2018)

Editorial: Glutamate-Related Biomarkers for Neuropsychiatric Disorders
por: Lin, Chieh-Hsin, et al.
Publicado: (2019)

Editorial: Temporal lobe dysfunction in neuropsychiatric disorder
por: Gao, Yujun, et al.
Publicado: (2022)

Neurological Soft Signs (NSS) in Census-Based, Decade-Adjusted Healthy Adults, 20 to >70 Years of Age
por: Bachmann, Silke, et al.
Publicado: (2021)

Editorial: Emotional Disturbance and Brain Imaging in Neuropsychiatric Disorders
por: Esposito, Roberto, et al.
Publicado: (2021)

Editorial: Epidemiology and clinical researches on neuropsychiatric disorders in aging
por: Xie, Wuxiang, et al.
Publicado: (2023)

Editorial: Unravelling the role of CB2r in neuropsychiatric diseases
por: Onaivi, Emmanuel S.
Publicado: (2023)

Association between neurological soft signs, temperament and character in patients with schizophrenia and non-psychotic relatives
por: Galindo, Liliana, et al.
Publicado: (2016)

Neurological soft signs (NSS) and cognitive impairment in chronic schizophrenia
por: Herold, Christina J., et al.
Publicado: (2018)

Editorial: Neurodevelopmental, neuropsychiatric and psychosocial correlates of joint hypermobility and related disorders
por: Guinchat, Vincent, et al.
Publicado: (2022)

Editorial: Neuroimaging insights into the link between sleep disturbances and neuropsychiatric disorders
por: von Deneen, Karen M., et al.
Publicado: (2023)

Disease Severity in Treatment Resistant Schizophrenia Patients Is Mainly Affected by Negative Symptoms, Which Mediate the Effects of Cognitive Dysfunctions and Neurological Soft Signs
por: Iasevoli, Felice, et al.
Publicado: (2018)

T8. NEUROLOGICAL SOFT SIGNS (NSS) IN SCHIZOPHRENIA: AN UPDATE ON THE STATE- VERSUS TRAIT-PERSPECTIVE
por: Bachmann, Silke, et al.
Publicado: (2018)

Neurological soft signs (NSS) and brain morphology in patients with chronic schizophrenia and healthy controls
por: Herold, Christina J., et al.
Publicado: (2020)

Neurological soft signs are increased in major depressive disorder irrespective of treatment
por: Schülke, Rasmus, et al.
Publicado: (2023)

Neurological soft signs and cognition in the late course of chronic schizophrenia: a longitudinal study
por: Herold, Christina J., et al.
Publicado: (2020)

Editorial: Mental Disorders Associated With Neurological Diseases
por: Yang, Yi, et al.
Publicado: (2020)

Editorial: Neurological and clinical aspects of perinatal mental health
por: Kingstone, Tom, et al.
Publicado: (2023)

T67. NEUROLOGICAL SOFT SIGNS IN THE COURSE OF SCHIZOPHRENIA: A LONGITUDINAL ANALYSIS IN CHRONIC SCHIZOPHRENIA
por: Herold, Christina, et al.
Publicado: (2018)

Editorial: The Emerging Role of SPECT Functional Neuroimaging in Psychiatry & Neurology
por: Henderson, Theodore A., et al.
Publicado: (2022)

Editorial: Environmental risk factors and inflammation in psychiatric and neurological disease
por: Meier, Ute-Christiane, et al.
Publicado: (2022)

Editorial: The affective side of Alzheimer's disease (AD): neuropsychiatric symptoms as early sentinel of cognitive decline and pathogenetic factors in disease progression
por: Cutuli, Debora, et al.
Publicado: (2023)

NMDA Receptor Activity in Neuropsychiatric Disorders
por: Lakhan, Shaheen E., et al.
Publicado: (2013)

Editorial: Cognitive, Psychological, and Psychiatric Consequences of the Coronavirus (COVID-19) Pandemic in the Population of Older Persons With Cognitive Impairment, Dementia, and/or Neuropsychiatric Disorders
por: Palmer, Katie, et al.
Publicado: (2021)

Editorial: Progress in Translational Neuroimaging: Integrating Pathways, Systems, and Phenomenology in Neurology and Psychiatry
por: Stoyanov, Drozdstoy, et al.
Publicado: (2020)

Neurological Soft Signs in Individuals with Pathological Gambling
por: Elman, Igor, et al.
Publicado: (2013)

The Effect of Methylphenidate on Neurological Soft Signs in ADHD
por: Hrtanek, Igor, et al.
Publicado: (2015)

F175. NEUROLOGICAL SOFT SIGNS (NSS) AND BRAIN MORPHOLOGY IN PATIENTS WITH CHRONIC SCHIZOPHRENIA AND HEALTHY CONTROLS
por: Herold, Christina, et al.
Publicado: (2018)

New Challenges and Frontiers in the Research for Neuropsychiatric Disorders
por: Tropea, Daniela
Publicado: (2012)

Neuropsychiatric Symptoms in Parkinson’s Disease: Beyond Complications
por: Kehagia, Angie A.
Publicado: (2016)

Fragile X-Associated Neuropsychiatric Disorders (FXAND)
por: Hagerman, Randi J., et al.
Publicado: (2018)

Editorial: Role of Neuroinflammation in the Neuropsychiatric and Neurological Aspects of COVID-19
por: Tremblay, Marie-Eve, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_84hg8252qbab9e7cb9pbqep5o9